CD4 and neoplasm: Requires generation of HLA multimer for each reactivityLimited number of HLA multimersPrior knowledge of the specific reactivity and HLA restriction requiredNot optimal for isolating tumor-reactive CD4+ T cellsSensitivity limited by the frequency of the neoantigen-specific population